Company / Income Tax per Share
Amneal Pharmaceuticals, Inc. Income Tax per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.06
FY2025
5-year range
$0.04 / $2.90
FY2021-FY2025
Trend
-48.8%
vs FY2024
Sector context
#49 of 201
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s income tax per share of $0.06 is higher than 76% of companies in the Health Care sector (FY2025). Income Tax per Share has fluctuated over the past 9 years, ranging from $-0.01 in FY2020 to $1998.00 in FY2017.
Based on SEC 10-K filings.
0.06 in FY2025 with a 3-year CAGR of +12.7%. Top quartile in the Health Care sector.
Improved from $0.07 to $0.06 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +12.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-95.3% below sector average
Key checks
Key Insights
- In FY2025, income tax per share decreased 48.8% year-over-year.
- Ranks #49 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2017.
- Lowest income tax per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.06 | -48.8% |
| FY2024 | $0.12 | +69.5% |
| FY2023 | $0.07 | +64.8% |
| FY2022 | $0.04 | -98.5% |
| FY2021 | $2.90 | +26121.6% |
| FY2020 | -$0.01 | -171.0% |
| FY2019 | $0.02 | -63.0% |
| FY2018 | $0.04 | -100.0% |
| FY2017 | $1998.00 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026